PharmaCyte Biotech Inc.

NASDAQ: PMCB · Real-Time Price · USD
1.02
0.12 (13.35%)
At close: Aug 18, 2025, 3:59 PM
1.02
0.00%
After-hours: Aug 18, 2025, 07:48 PM EDT

PharmaCyte Biotech Revenue

PharmaCyte Biotech reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending April 30, 2025, PharmaCyte Biotech generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
2
Market Cap
6.93M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Apr 30, 2025 0 n/a
Apr 30, 2024 0 n/a
Apr 30, 2023 0 n/a
Apr 30, 2022 0 n/a
Apr 30, 2021 0 n/a
Apr 30, 2020 0 n/a
Apr 30, 2019 0 n/a
Apr 30, 2018 0 n/a
Apr 30, 2017 0 n/a
Apr 30, 2016 0 n/a
Apr 30, 2015 0 n/a
Apr 30, 2014 0 -100.00%
Apr 30, 2013 12.16K -81.73%
Apr 30, 2012 66.56K -47.17%
Apr 30, 2011 126K -52.08%
Apr 30, 2010 262.93K -59.74%
Apr 30, 2009 653.13K -45.11%
Apr 30, 2008 1.19M +1.71%
Apr 30, 2007 1.17M +117.86%
Apr 30, 2006 537.04K +521.76%
Apr 30, 2005 86.37K +3524.59%
Apr 30, 2004 2.38K +Infinity%
Apr 30, 2003 0 n/a
Apr 30, 2002 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.